Skip to content

TAG at Ten: The Year 2001

  • Chad Cipiti

January: TAG's Gregg Gonsalves becomes GMHC Director of Treatment Policy. Completion of STI Workshop 2000 report. FDA hearing on salvage therapy trial design. Merck meeting on promising DNA/adenovirus HIV vaccine. TAG mobilizes 600 signatures on global letter to Glaxo decrying…

Read more

Consensus Statement: AIDSVAX Fails to Protect

  • Chad Cipiti

VaxGen's Claims of Efficacy in Black and Asian Participants Are Misleading and Premature 24 February 2003The undersigned community-based HIV/AIDS organizations are deeply concerned by today's presentation of data from the phase III clinical trial of VaxGen's HIV vaccine candidate, AIDSVAX.…

Read more

TAG at Ten: The Year 2000

  • Chad Cipiti

January: NIH workshops on long term effectiveness research, studies designed to look at "when to start" and switch HAART, and for long-term side effects. TAG hires Yvette Delph as new Antiviral Project Director. Completion of TAG's AIDS Vaccine Research at…

Read more

TAG at Ten: The Year 1999

  • Chad Cipiti

January: amfAR's Paul Corser dies after a nine-year struggle with AIDS. FDA approves Glaxo's atovaquone (Mepron) for the prevention of PCP pneumonia. ACT UP/Needle Exchange activist Rod Sorge dies. Retrovirus conference, Chicago. Beatrice Hahn presents on the HIV-1's chimp origins;…

Read more
Back To Top